Edward C. Saltzman - Sep 12, 2022 Form 4 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role
Director
Signature
/s/ Christine Ring, as Attorney-in-Fact for Edward C. Saltzman
Stock symbol
NRIX
Transactions as of
Sep 12, 2022
Transactions value $
$0
Form type
4
Date filed
9/14/2022, 04:25 PM
Next filing
May 4, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 1/36 of the total shares monthly beginning October 12, 2022 until the option is fully vested on September 12, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date.